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Key questions
 ► The prehospital 12- lead ECG (PHECG) is associated 
with better survival in patients with acute coronary 
syndrome (ACS), but is potentially underused.
 ► In this study, we will examine whether the propor-
tion of patients who receive PHECG has changed 
in the primary percutaneous coronary intervention 
era. In addition, we will look at barriers and facil-
itators of PHECG use in terms of patient- related 
factors and emergency medical services personnel 
perspectives.
 ► Findings from this study will provide an insight into 
PHECG use in patients with ACS and allow the de-
velopment and testing, in a randomised trial, of an 
intervention to improve uptake.
AbstrAct
Introduction Use of the prehospital 12- lead ECG (PHECG) 
is recommended in patients presenting to emergency 
medical services (EMS) with suspected acute coronary 
syndrome (ACS). Prior research found that although PHECG 
use was associated with improved 30- day survival, a third 
of patients (typically women, the elderly and those with 
comorbidities) under EMS care did not receive a PHECG.
The overall aim of the PHECG2 study is to update 
evidence on care and outcomes for patients eligible for 
PHECG, specifically addressing the following research 
questions: (1) Is there a difference in 30- day mortality, 
and in reperfusion rate, between those who do and those 
who do not receive PHECG? (2) Has the proportion of 
eligible patients who receive PHECG changed since the 
introduction of primary percutaneous coronary intervention 
networks? (3) Are patients that receive PHECG different 
from those that do not in terms of social and demographic 
factors, or prehospital clinical presentation? (4) What 
factors influence EMS clinicians’ decisions to perform 
PHECG?
Methods and analysis This is an explanatory, mixed- 
method study comprising four work packages (WPs). WP1 
is a population- based, linked- data analysis of a national 
ACS registry (Myocardial Ischaemia National Audit Project). 
WP2 is a retrospective chart review of patient records from 
three large regional EMS. WP3 comprises focus groups of 
EMS personnel. WP4 will synthesise findings from WP1–3 
to inform the development of an intervention to increase 
PHECG uptake.
Ethics and dissemination The study has been approved 
by the London- Hampstead Research Ethics Committee 
(ref: 18LO1679). Findings will be disseminated through 
feedback to participating EMS, conference presentations 
and publication in peer- reviewed journals.
Trial registration number NCT03699137
InTroduCTIon
The performance of a 12- lead ECG is recom-
mended in the assessment of patients with 
suspected acute coronary syndrome (ACS) 
presenting in the community to emergency 
medical services (EMS).1–3 A prehospital 
12- lead ECG (PHECG) informs decision- 
making in three components of immediate 
care: targeted prehospital treatment, trans-
port to an appropriate receiving hospital and 
provision of information required to activate 
a response from the receiving cardiac cath-
eter laboratory when ST- segment elevation 
myocardial infarction (STEMI) is suspected.4
This study builds on our previous research, 
which reported an association between 
PHECG and lower short- term mortality 
following STEMI and non- STEMI (30- day 
mortality 7.4% vs 8.2%, OR 0.94, 95% CI 0.91 
to 0.96).5 Earlier research focused on the asso-
ciation of PHECG with process- of- care quality 
descriptors such as ‘call- to- reperfusion’ 
time.6 7 A subsequent systematic review and 
meta- analysis has confirmed the association 
of PHECG with improved clinical outcomes,8 
and this evidence has been incorporated 
into international guidelines and quality 
indicators for prehospital care of patients 
with ACS.2 3 However, we found PHECG was 
underused, particularly in older patients, 
women and people with comorbidities.5
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We showed that women were less likely to receive 
PHECG than men (OR 0.87, 95% CI 0.86 to 0.89),5 and 
suggested that this may be because the majority of EMS 
personnel at that time were male. The lower rate of 
PHECG in women was also reported from the national 
SWEDEHEART (The Swedish Web- system for Enhance-
ment and Development of Evidence- based care in Heart 
disease Evaluated According to Recommended Thera-
pies) registry (OR 0.89, 95% CI 0.87 to 0.92),9 though 
these authors offered a different explanation related 
to ‘uncontrolled confounding of presenting symptoms 
and type of myocardial infarction’. A systematic review 
reported that women are less likely to present with chest 
pain and more likely to have prior heart failure, which 
may ‘mask’ the true diagnosis.10
Emergency situations force clinicians into a reliance 
on past experiences,11 12 intuition and personal decision 
rules (‘rules of thumb’),13 even though these approaches 
are potential sources of error and bias.14 In prehospital 
emergency care, suggested influences on clinical deci-
sions include a desire to ‘cover one’s back’,15 pragma-
tism (busy shift or end of a shift)16 and multilevel system 
influences.17
Since our earlier study there has been significant 
change in reperfusion strategies for STEMI in the UK, 
with primary percutaneous coronary intervention (pPCI) 
superseding fibrinolytic treatment as the treatment of 
choice.18 This has required changes in EMS organisation 
and practice, including direct transportation to pPCI- 
capable hospitals and the atrophy of existing programmes 
of prehospital administration of thrombolytic treatment 
by ambulance paramedics.
Considering this major change in practice and 
an increased emphasis on PHECG in guidelines, we 
expected there to be an increase in the use of PHECG 
since our first report. On the contrary, it appears to have 
declined to 64% for STEMI and 44% for non- STEMI, 
respectively, in 2015–2016 (National Institute for Cardio-
vascular Outcomes Research (NICOR), personal commu-
nication). It is therefore timely to update our analysis on 
a more recent cohort of patients and to explore potential 
determinants of why PHECG is/is not recorded.
Our a priori hypotheses are:
a. PHECG use by EMS personnel is associated with more 
timely processes of care and a lower short- term mortal-
ity rate in patients with suspected ACS, for both STEMI 
and non- STEMI cases.
b. Patients who do not receive a PHECG systematically 
differ from those who do.
c. EMS clinician decision- making regarding PHECG is 
influenced by more than clinical (pathophysiological) 
characteristics.
d. It is possible to use the findings from this study as the 
first stage of the development and subsequent evalua-
tion of a complex intervention19 designed to improve 
the uptake of PHECG.
Our research questions (with their respective work 
packages (WP)) are:
 ► For patients presenting to EMS with suspected ACS, is 
there a difference in 30- day mortality and reperfusion 
strategy in patients managed outside hospital by EMS 
between those who do and those who do not receive 
a PHECG? (WP1)
 ► Has the proportion of eligible patients who received 
a PHECG changed since the national rollout of pPCI 
networks? (WP1)
 ► Are patients that receive a PHECG different from 
those that do not in terms of social and demographic 
factors, and in their prehospital clinical presentation? 
(WP2)
 ► What factors do EMS clinicians report as influencing 
their decision to perform a PHECG? (WP3)
METhods and analysIs
To answer our research questions an explanatory, mixed- 
method study will be undertaken,20 in which the qualita-
tive data will be used to aid understanding of the quanti-
tative findings, consisting of the following four WPs:
WP1—population- based, linked cohort study using Myocar-
dial Ischaemia National Audit Project (MINAP) data from 
2010 to 2017 to update evidence on care and outcomes for 
patients eligible for PHECG. MINAP is a comprehensive 
registry of ACS hospitalisations mandated by the Depart-
ment of Health. Each MINAP entry provides patient 
demographic and clinical details of the patient journey 
across 122 data items. Data collection and management 
have been described previously.21
WP2—retrospective chart review22 of EMS records to collect 
data on factors recorded by EMS staff that may be associ-
ated with PHECG use, but are not routinely collected in 
MINAP.
WP3—EMS clinician self- report on PHECG recording, 
using focus groups.
WP4—synthesis of the findings from WP1, WP2 and WP3. 
This will be conducted to address our research questions, 
within our aim of using qualitative findings as explanatory 
of quantitative results20 and with the understanding that 
these data are intended as the development phase for the 
design of a complex intervention for further testing.19
study setting
WP1 will use existing data from MINAP, covering England, 
Wales and Northern Ireland.
For WP2 and WP3, data will be collected at three partic-
ipating EMS in England and Wales.
study population
WP1: patients will be eligible for the study if aged 18 
years or older when attended by EMS and admitted with 
ACS between 1 January 2010 and 31 December 2017 to 
one of 228 participating hospitals in England, Wales and 
Northern Ireland mandated to enter data into MINAP. 
For patients with multiple admissions, only the earliest 
record of their ACS event in MINAP will be used.
MINAP is overseen by a multiprofessional Domain 
Expert Group of stakeholders within the National 
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Cardiac Audit Programme (NCAP). As such, this study 
will include data collected on behalf of the British Cardio-
vascular Society under the auspices of NCAP, in which 
patient identity is protected.21
WP2 will include a stratified random sample of patients 
with suspected ACS (by initial diagnosis in MINAP) 
attended by one of the three participating EMS during 
the study period. It will include those with or without 
PHECG.
WP3 will include a purposive sample of EMS clinicians 
of different clinical grades, with varying levels of expe-
rience in caring for patients with ACS in the prehos-
pital setting, who are trained in the use of PHECGs and 
employed by one of the three participating EMS.
Main outcome measures
WP1—all- cause 30- day mortality (the proportion of 
patients who die from any cause within 30 days of the date 
of their event) calculated from linked MINAP and Office 
for National Statistics (ONS, Civil Registry) mortality 
data.
 ► Proportion of eligible patients for whom PHECG 
performed over time.
WP2—factors that may influence the use of PHECG in 
ACS (eg, patient symptoms, prehospital diagnosis, recog-
nition of ACS, EMS clinician training level and gender, 
patient refusal, patient ethnicity, language spoken, 
capacity to communicate and/or consent).
WP3—an understanding of influences on clinical 
decision- making regarding recording of the PHECG in 
ACS (and thereby, potential explanations of quantita-
tively measured rates of PHECG use).
Estimated sample size
WP1: all eligible patients in MINAP will be included 
in analysis. Formal power calculations are therefore 
unnecessary, but we anticipate that data extraction and 
linkage will generate a dataset comprising over 500 000 
cases.
WP2: we will sample 1650 cases at random from the 
MINAP database using a stratified sampling method. We 
will oversample by 10% (165 cases) to allow for any cases 
where the corresponding EMS clinical records cannot 
be located. Based on information received from NICOR, 
we expect approximately a 2:1 ratio of PHECG cases to 
non- PHECG cases (NICOR, personal communication). 
Assuming this, we will have 80% power (using 5% signif-
icance) in detecting a standardised statistical effect of 
0.15.
WP3: six EMS clinician focus groups (two per EMS), 
each comprising up to eight participants, will be 
convened, purposively sampling to capture the views of 
staff in both urban and rural settings within large EMS. 
We aim to obtain depth with a sample size that is neither 
too small to contain various aspects of the phenomenon 
nor too large to allow depth of analysis in this qualitative 
study.23
data collection
WP1: we will use existing MINAP registry data, collected 
prospectively at each hospital using a secure electronic 
system, encrypted and transferred online to a central 
database in which patient identity is protected.21 We will 
link MINAP data to ONS Civil Registry mortality data at 
individual level through NHS Digital.
WP2: we will randomly select a cohort of patients with 
and without PHECG, with ACS recorded in MINAP, for 
the three participating EMS using a unique identifier for 
patients in MINAP who came to hospital via EMS. The 
sample will be stratified by preagreed demographic vari-
ables (such as sex and age band) to ensure it is sufficiently 
representative. We will report key characteristics of the 
sample, those of the MINAP ACS subpopulation (those 
who came via EMS), and the overall MINAP population.
We will employ and train paramedic researchers 
at each site to retrieve and extract data from the EMS 
records of each sampled patient. We will collect data on 
factors that may influence the use of a PHECG which are 
not recorded in MINAP, including coded data on patient 
symptoms, prehospital diagnosis of ACS, EMS clinician 
training level and sex, patient refusal, patient ethnicity, 
language spoken, capacity to communicate and/or 
consent. The paramedic researchers will extract relevant 
narrative data from the ‘free- text’ section within EMS 
records. A second researcher will independently extract 
data for a random sample of 10% of the cases for quality 
assurance purposes.
WP3—we will conduct focus groups using a semistruc-
tured approach, aiming to explore the views of EMS clini-
cians about the role of PHECG, experiences of assessing 
patients with STEMI and non- STEMI, and influences on 
whether or not to record a PHECG. A topic guide will 
be constructed in the context of the quantitative findings 
and with input from EMS clinicians, patient and public 
representatives, and in the context of literature that high-
lights complexity and multiple influences on decisions 
made in the EMS setting. Focus group discussions will 
be digitally recorded and transcribed verbatim. Partici-
pants will be briefed at recruitment and at the beginning 
of each focus group not to disclose any information that 
might serve to identify individual(s).
analysis
WP1—available demographic data will be presented 
using interval categories for continuous variables where 
appropriate. We will present mortality as (1) the propor-
tion occurring within 30 days of hospitalisation, and (2) 
time to death, summarised using Kaplan- Meier survival 
curves. We will estimate (with 95% CIs) the outcomes 
associated with the performance of PHECG via a binary 
variable, adjusting for other statistically significant demo-
graphic and clinical variables.
A similar modelling approach will be used for other 
categorical variables of interest (for instance, use of 
reperfusion); natural extensions within the framework of 
copyright.
 o
n
 D
ecem
ber 17, 2019 at Swansea University. Protected by
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2019-001156 on 2 Decem
ber 2019. Downloaded from
 
Open Heart
4 Gavalova L, et al. Open Heart 2019;6:e001156. doi:10.1136/openhrt-2019-001156
generalised linear models will cover both the analysis of 
any counts and measurement outcomes of interest.
WP2—partitioning our sample of ACS cases by PHECG 
or not, we will use univariate and multivariate analyses 
to explore differences in patient symptoms and other 
factors between these two groups; we will report and 
explore differences across stratifying variables (such as 
age band, sex), and across categorisations emerging from 
consideration of free- text narratives in EMS records). We 
will use binary logistic regression to explore the extent 
to which factors are associated with PHECG use or not in 
ACS cases, reporting odds ratios (with 95% CIs) for statis-
tically significant variables. Inter- rater reliability of data 
retrieval will be assessed using Cohen’s kappa.
WP3—focus group transcripts will be managed using 
NVivo software.24 Initially, we will conduct an inductive 
thematic analysis, using bracketing, and with iteration 
to the coding framework based on deep reading of the 
data, discussion within the research team and member 
checking. We will then use framework analysis23 and 
analyse whether the generated themes show consensus or 
dissent when considered against any differences in the 
characteristics of the focus group participants (eg, grade 
of EMS clinician, local practice). At least two researchers 
will read, reread and draft a coding framework for discus-
sion and blinded application to at least two transcripts. 
The coding framework will be developed iteratively by 
discussion throughout the analysis process. Researchers 
involved in the qualitative data collection and analysis will 
meet regularly to reflect on their assumptions, personal 
influences and data interpretations.
WP4—evidence from the WPs will be presented to a 
wider consultative group of study participants including 
local EMS collaborators and patient and public repre-
sentatives. This wider group will be invited to discuss 
and help the research team interpret the emerging find-
ings. WP leaders will collaborate through discussion to 
reach agreement on the evidence against each research 
question.
Patient and public involvement (PPI)
Patients and public representatives (PPI) have been 
involved in the study since its inception. They played a 
significant role in the development of the research ques-
tions, understanding their relevance to the problem 
area, the study proposal and the funding application. 
PPI colleagues’ involvement will continue through their 
participation in the study oversight activities, in the inter-
pretation of the study results and subsequently in the 
dissemination of the findings via their local networks and 
other appropriate routes.
Clinical and public health implications
Understanding the clinical and non- clinical factors influ-
encing EMS clinicians’ decisions to record a PHECG will 
enable us to develop (and later, test in a randomised 
trial) an intervention with the potential to improve 
PHECG uptake and patient outcomes following an ACS 
event. With over 85 000 admissions with acute myocardial 
infarction recorded in MINAP each year, and millions 
worldwide, the potential for this research to improve 
outcomes nationally and internationally is substantial.
strengths and limitations of the study
The main limitation of the study is its observational, 
cross- sectional nature, which prevents us from inferring 
causal relationships. Retrospective chart review methods, 
although commonly used in emergency research, are not 
without shortcomings22; for example, they are subject to 
bias by the data abstractors’ through misinterpretation of 
chart entries or miscoding of data during data abstraction 
leading to either random or systematic errors. To mini-
mise the effect of those shortcomings, recommended 
measures from published methodological standards22 
have been implemented in the design of WP2.
The main strengths of the study are the very large popu-
lation included in WP1, and its multifaceted, multicentre 
approach to understanding barriers and facilitators in 
performing PHECG.
EThICs and dIssEMInaTIon
The study has been approved by the London- Hampstead 
Research Ethics Committee (ref: 18LO1679). For patient 
data used in WP1 and WP2 without patient consent, we 
have obtained section 251 support from the Confiden-
tiality Advisory Group (ref: 18CAG0164) issued by the 
Health Research Authority. Participating EMS sites will 
conduct the study in compliance with the protocol. The 
study is overseen by a study management group and 
steering committee with an independent chair.
Findings from this study will be submitted for publi-
cation in peer- reviewed scientific journals. We will also 
present our findings to members of the public and 
professional stakeholders at local meetings in the three 
participating EMS, at internal academic seminars, and at 
national and international conferences relevant to emer-
gency cardiovascular care.
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